Work

Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety

Year: 2019

Type: article

Study design: Clinical Trial

Source: European Journal of Nuclear Medicine and Molecular Imaging

DOI: 10.1007/s00259-019-04567-2

Authors: Sanjana Ballal, Madhav Prasad Yadav, Chandrasekhar Bal, Ranjit Kumar Sahoo, Madhavi Tripathi

Institutions: All India Institute of Medical Sciences, DR. B.R.A. Institute Rotary Cancer Hospital

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2984721232

FWCI: 9.548

Cites: 23

Cited by: 221

Related to: 10